MPS Limited Details Funding Plan for Unbound Medicine Acquisition via Subsidiary

MPS Limited ( (IN:MPSLTD) ) has shared an update.

MPS Limited has detailed the funding structure for its wholly owned subsidiary MPS North America LLC’s proposed USD 16.5 million acquisition of US-based Unbound Medicine, Inc. The deal will be financed through a mix of internal accruals, inter-company loans, and external borrowing, including a USD 3 million loan from subsidiary American Journal Experts, a USD 1.94 million loan from MPS Limited, and a proposed INR 420 million term loan from ICICI Bank that will support an equity infusion of around USD 9.81 million into MPS North America LLC. The subsidiary will remain 100% owned by MPS before and after the equity infusion, and the company emphasized that all funding arrangements and any additional minor inter-company loans from group entities will comply with Indian foreign exchange and overseas investment regulations. The structured financing underlines MPS’s capital deployment strategy for overseas acquisitions and signals a continued push to expand its presence in specialized digital and medical information markets without diluting ownership in its key North American arm.

More about MPS Limited

MPS Limited operates in the content and publishing solutions industry, providing technology-enabled services through its global subsidiaries, including MPS North America LLC and American Journal Experts, LLC. The company focuses on serving international clients, particularly in knowledge, research, and education segments, and leverages cross-border structures to manage and grow its portfolio of specialized content and digital solutions businesses.

Average Trading Volume: 1,246

Technical Sentiment Signal: Buy

Current Market Cap: 32.45B INR

See more data about MPSLTD stock on TipRanks’ Stock Analysis page.